TRPM3 as a novel target to alleviate acute oxaliplatin-induced peripheral neuropathic pain

Chemotherapy-induced peripheral neuropathic pain (CIPNP) is an adverse effect observed in up to 80% of patients of cancer on treatment with cytostatic drugs including paclitaxel and oxaliplatin. Chemotherapy-induced peripheral neuropathic pain can be so severe that it limits dose and choice of chemo...

Descripción completa

Detalles Bibliográficos
Autores principales: Aloi, Vincenzo Davide, Pinto, Sílvia João Poseiro Coutinho, Van Bree, Rita, Luyten, Katrien, Voets, Thomas, Vriens, Joris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10436359/
https://www.ncbi.nlm.nih.gov/pubmed/37079852
http://dx.doi.org/10.1097/j.pain.0000000000002906

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10436359/
https://www.ncbi.nlm.nih.gov/pubmed/37079852
http://dx.doi.org/10.1097/j.pain.0000000000002906

Ejemplares similares